Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about C3AR: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | C3AR |
| Key Genes/Proteins | BETA_CATENIN, C3, C3A, GSK3B |
| Related Diseases | DENDRITIC_MORPHOLOGY |
Knowledge base pages for this entity
graph TD
C3AR["C3AR"]
C3AR -->|"modulates"| Neuronal_Apoptosis["Neuronal Apoptosis"]
C3AR -->|"downregulates"| __catenin_Signaling["beta-catenin Signaling"]
C3AR -->|"inhibits"| DENDRITIC_MORPHOLOGY["DENDRITIC_MORPHOLOGY"]
C3AR -->|"activates"| MICROGLIA["MICROGLIA"]
C3AR -->|"regulates"| BETA_CATENIN["BETA_CATENIN"]
C3AR -->|"activates"| GSK3B["GSK3B"]
C3["C3"] -->|"binds"| C3AR
C3A["C3A"] -->|"binds"| C3AR
Complement_C3["Complement C3"] -->|"interacts"| C3AR
SB290157["SB290157"] -->|"inhibits"| C3AR| Target | Relation | Type | Str |
|---|---|---|---|
| ASTROCYTES | mediates | cell_type | 0.85 |
| NEURON | mediates | cell_type | 0.85 |
| MICROGLIA | mediates | cell_type | 0.85 |
| ASTROCYTE | interacts_with | cell_type | 0.80 |
| neurodegeneration | therapeutic_target_for | disease | 0.70 |
| feedback loop | associated_with | phenotype | 0.70 |
| Synapse Engulfment | mediates | phenotype | 0.70 |
| synapse loss | mediates | phenotype | 0.70 |
| microglia | regulates | cell_type | 0.70 |
| Ad | targets | disease | 0.70 |
| MICROGLIA | activates | cell_type | 0.64 |
| DENDRITIC_MORPHOLOGY | inhibits | phenotype | 0.64 |
| cognitive impairment | associated_with | disease | 0.60 |
| GSK3B | activates | protein | 0.56 |
| BETA_CATENIN | regulates | protein | 0.56 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate | 0.749 | alzheimers-disease-parkinsons | - |
| C3aR Blockade Disrupts the Microglial-Astrocyte Feedforward | 0.651 | neuroinflammation | What molecular mechanisms determine whet |
| Complement Cascade Specificity: Microglial C3aR Antagonism D | 0.618 | synaptic-biology | Does SPP1-mediated synaptic engulfment r |
| Complement C3/C3aR Synaptic Protection Therapy | 0.000 | - | Immune atlas neuroinflammation analysis |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-12 | 0 hypotheses
synaptic biology | 2026-04-07 | 8 hypotheses Top: 0.813
neurodegeneration | 2026-04-01 | 14 hypotheses Top: 0.729
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PINK1 mutation carriers frequently report experiencing pain. | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
| Evidence regarding pain in DNAJC6 pathogenic variants is limited and i | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
| Identification of a vulnerable subtype of dopaminergic neurons co-expr | genetic_association | Parkinson's disease | 0.500 | 0.00 | mouse | extracted | N/A |
| Evidence regarding pain in SYNJ1 pathogenic variants is limited and in | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
| Anxa1+ DANs show selective earlier loss compared to other dopaminergic | neuropathology | Parkinson's disease | 0.500 | 0.00 | mouse | extracted | N/A |
| Released prosaposin (PSAP) was shown to induce interleukin-6 (IL-6) up | cell_biology | Parkinson's disease | 0.500 | 0.00 | cell_culture | extracted | N/A |
| Evidence regarding pain in FBXO7 pathogenic variants is limited and in | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
| Evidence regarding pain in ATP13A2 pathogenic variants is limited and | genetic_association | Parkinson's disease | 0.500 | 0.00 | human | extracted | N/A |
| Inhibition of transmitter release specifically in Anxa1+ neurons was s | animal_model | Parkinson's disease | 0.500 | 0.00 | mouse | extracted | N/A |
| Identified a subtype of Sox6+ Anxa1+ dopaminergic neurons that are sel | neuropathology | Parkinson's disease | 0.500 | 0.00 | mouse | extracted | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.69 · 2026-04-21
closed · Rounds: 4 · Score: 0.58 · 2026-04-16
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
Hypotheses and analyses mentioning C3AR in their description or question text
No additional research found